Israele - ebraico - Ministry of Health

gsk consumer healthcare, israel ltd - nicotine - לכסניה - nicotine 2 mg - nicotine - nicotine - an aid to smoking cessation, relief of symptoms associated with nicotine withdrawal.in smokers currently unable or not ready to stop smoking abruptly the lozenges may also be used as part of a program to reduce smoking prior to stopping completely.

Israele - ebraico - Ministry of Health

gsk consumer healthcare, israel ltd - nicotine - לכסניה - nicotine 1 mg - drugs used in nicotine dependence - as an aid to smoking cessation and for the relief of nicotine withdrawal symptoms. in smokers currently unable or not ready to stop smoking abruptly the gum may also be used as part of a program to reduce smoking prior to stopping completely.

Israele - ebraico - Ministry of Health

j-c health care ltd - rilpivirine - rilpivirine 300 mg / 1 ml - rilpivirine

Israele - ebraico - Ministry of Health

gsk consumer healthcare, israel ltd - xylometazoline hydrochloride - תמיסה - xylometazoline hydrochloride 0.1 %w/v - xylometazoline - xylometazoline - nasal congestion in acute colds, vasomotor rhinitis, hay fever, rapid relief of nasal congestion for up to ten hours.

Israele - ebraico - Ministry of Health

j-c health care ltd - golimumab - תמיסה להזרקה - golimumab 50 mg / 0.5 ml - golimumab - golimumab - rheumatoid arthritis :simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (dmard) therapy including mtx has been inadequate.psoriatic arthritis :simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (dmard) therapy has been inadequate.ankylosing spondylitis :simponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.

Israele - ebraico - Ministry of Health

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara™ is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to,or have contraindication to or who are intolerant to other systemic therapies including ciclosporin,methotrexate and psoralen plus u.v (puva).

Israele - ebraico - Ministry of Health

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to, or have contraindication to or who are intolerant to other systemic therapies including ciclosporin, methotrexate and psoralen plus u.v (puva).

Israele - ebraico - Ministry of Health

j-c health care ltd - topiramate - טבליות מצופות פילם - topiramate 25 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Israele - ebraico - Ministry of Health

j-c health care ltd - topiramate - טבליות מצופות פילם - topiramate 50 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Israele - ebraico - Ministry of Health

j-c health care ltd - topiramate - טבליות מצופות פילם - topiramate 100 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.